https://www.selleckchem.com/pr....oducts/gc7-sulfate.h
Rationale Approximately one-third of patients with obstructive sleep apnea (OSA) treated with hypoglossal nerve stimulation (HGNS) therapy are incomplete responders, despite careful patient selection based on baseline characteristics and drug-induced sleep endoscopy.Objectives Here we use polysomnographic endotyping to assess the pathophysiological mechanisms underlying favorable versus incomplete responses to HGNS therapy.Methods Baseline polysomnography data of the STAR (Stimulation Therapy for Apnea Reduction) trial were included
Like
Comment
Share
